ABEONA THERAPEUTICS INC. (ABEO)
Q2 2026Earnings receipt·reported Aug 13, 2026 · Before Open·quarter ended Jun 30, 2026
Rev Miss -6.4%
The street expected
EPS consensus
-$0.23
4 analysts · street range -$0.28 – -$0.19
By basis
-$0.24 adj · -$0.23 GAAP
adjusted / GAAP consensus, same frozen snapshot
Revenue consensus
$12.2M
6 analysts
Year-ago EPS
($0.58)
same basis as the consensus row
frozen Aug 13, 2026 — before the print erased it
The company printed
EPS (GAAP)
($0.35)
Revenue
$11.4M
Revenue vs street
-6.4%
against $12.2M — stockanalysis consensus, pre-report snapshot
verified from the wire release · figures published 7:31 AM ET
The next-quarter bar, as it stood at the print
-$0.11 adj EPS$20.0M revenuefor the quarter ending Sep 30, 2026 · 6 analysts
any guidance in this release was set against this baseline — it rolls forward and vanishes once the street re-models
Consensus into the print
The bar held at -$0.23 across 5 nightly snapshots into the print.
Aug 9, 2026Aug 13, 2026
Why this page exists
Every public surface destroys the “expected” number at the moment it matters: the actual overwrites it, and post-hoc surprise figures get computed against restated consensus. This receipt was frozen from Wall St Engine’s nightly expectation archive before the print and joined to figures verified from the release itself. It does not update, and it cannot be reconstructed after the fact.
receipt frozen 2026-08-13 11:31 UTC · actuals last refined 2026-08-16 03:53 UTC · ABEO company page